(Reuters) - The company said it earned $706 million, or 36 cents per share, in the second quarter, compared with $667 million, or 34 cents per share, in the year-earlier period.
Excluding special items, the New York-based drugmaker earned 37 cents per share. Analysts on average expected 36 cents per share, according to Reuters Estimates.
Read more at Reuters.com Market News
Excluding special items, the New York-based drugmaker earned 37 cents per share. Analysts on average expected 36 cents per share, according to Reuters Estimates.
Read more at Reuters.com Market News
No comments:
Post a Comment